English | 繁體

Search in the results

UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Codelivery of Doxorubicin and shAkt1 by Poly(ethylenimine)-Glycyrrhetinic Acid Nanoparticles to Induce Autophagy-Mediated Liver Cancer Combination Therapy Journal article
Feng-Zhen Wang, Lei Xing, Zheng-hai Tang, Jin-Jian Lu, Peng-Fei Cui, Jian-Bing Qiao, Lei Jiang, Hu-Lin Jiang, Li Zong. Codelivery of Doxorubicin and shAkt1 by Poly(ethylenimine)-Glycyrrhetinic Acid Nanoparticles to Induce Autophagy-Mediated Liver Cancer Combination Therapy[J]. Molecular Pharmaceutics, 2016, 13(4), 1298-1307.
Authors:  Feng-Zhen Wang;  Lei Xing;  Zheng-hai Tang;  Jin-Jian Lu;  Peng-Fei Cui; et al.
Favorite | TC[WOS]:54 TC[Scopus]:53 | Submit date：2018/12/28
Autophagy  Combination Therapy  Glycyrrhetinic Acid  Liver Cancer Targeting  Self-assembled  
Codelivery of Doxorubicin and shAkt1 by Poly ethylenimine)−Glycyrrhetinic Acid Nanoparticles To Induce Autophagy-Mediated Liver Cancer Combination Therapy Journal article
Wang, FZ, Xing, L, Tang, ZH, Lu, J., Cui, PF, Qiao, JB, Jiang, L, Jiang, HL, Zhong, L. Codelivery of Doxorubicin and shAkt1 by Poly ethylenimine)−Glycyrrhetinic Acid Nanoparticles To Induce Autophagy-Mediated Liver Cancer Combination Therapy[J]. Molecular Pharmaceutics, 2016, 1298-1307.
Authors:  Wang, FZ;  Xing, L;  Tang, ZH;  Lu, J.;  Cui, PF; et al.
Favorite |   IF:4.5/4.6 | Submit date：2022/08/26
combination therapy  self-assembled  glycyrrhetinic acid  liver cancer targeting  autophagy